tailieunhanh - Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment

Thromboprophylaxis dosing strategies using enoxaparin in elderly patients with renal disease are limited, while dose adjustments or monitoring of anti-Xa levels are recommended. We sought to evaluate the efficacy and safety of enoxaparin 20 mg versus 30 mg subcutaneously daily by comparing anti-Xa levels, thrombosis and bleeding. | Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment

TỪ KHÓA LIÊN QUAN